Found: 5
Select item for more details and to access through your institution.
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2494, doi. 10.1111/cts.13624
- By:
- Publication type:
- Article
Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 260, doi. 10.1111/bcp.14956
- By:
- Publication type:
- Article
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 6, p. 1324, doi. 10.1111/bcp.12724
- By:
- Publication type:
- Article
Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
- Published in:
- Pediatric Allergy & Immunology, 2005, v. 16, n. 3, p. 209, doi. 10.1111/j.1399-3038.2005.00264.x
- By:
- Publication type:
- Article